Mayne Pharma | MYX - Betriebsaufwand

Aktienkurs
2.84
Täglich Wechseln
-0.03 -1.05%
Monatlich
25.11%
Jährlich
-59.43%
Q2 Prognose
2.52




Betriebsaufwand Veränderung Datum
Ansell USD 880.1M 465.65M 2025-12
Avita Medical AUD 28.02M 1.55M 2025-12
Cochlear AUD 914.9M 454.8M 2025-12
CSL USD 5.7B 2.82B 2025-12
Healius AUD 684.9M 261.2M 2024-12
Integral Diagnostics AUD 219.16M 66.76M 2024-06
Medical Developments International AUD 21.61M 11.59M 2025-12
Nanosonics AUD 93.11M 45.89M 2025-12
Polynovo AUD 68.22M 1.24M 2025-12
Ramsay Health Care AUD 8.8B 83.5M 2025-12
ResMed USD 922.51M 49.28M 2025-12
Sigma Healthcare AUD 1.68B 174.89M 2024-12
Sonic Healthcare AUD 4.23B 2.14B 2024-12
Telix Pharmaceuticals AUD 405.4M 26.29M 2025-12